Your Location:
Home >
Browse articles >
Effect of Astragalus Polysaccharide on EMT of A549/DDP Lung Adenocarcinoma Xenograft: An Exploration Based on PI3K/Akt Signaling Pathway
Updated:2021-10-29
    • Effect of Astragalus Polysaccharide on EMT of A549/DDP Lung Adenocarcinoma Xenograft: An Exploration Based on PI3K/Akt Signaling Pathway

    • ZHANG Ying , WANG Chun , YU Dan , GAO Yuan , JING Huan , WANG Ying , LIU Chun-ying
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 27, Issue 23, Pages: 51-58(2021)
    • DOI: 10.13422/j.cnki.syfjx.20212323     

      CLC:

    Scan QR Code

  •  
  •  
  • Full Text(HTML)

  • Figs( 6 ) Tabs( 5 )

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

122

Views

102

Downloads

2

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Integrating Transcriptomics and 3D Organoids to Investigate Mechanism of Periplaneta americana Extract Against Lung Adenocarcinoma
Mechanisms of Oxyresveratrol in Inhibiting Epithelial-mesenchymal Transition in Non-small Cell Lung Cancer via PI3K/Akt Signaling Pathway
Mechanism of Modified Si Junzitang and Shashen Maidong Tang in Improving Sensitivity of Cisplatin in EGFR-TKI Resistant Lung Adenocarcinoma Cells Based on Aerobic Glycolysis
Effect of Yiqi Yangyin Jiedu Prescription on sPD-L1 in Peripheral Blood of Patients Treated with EGFR-TKIs and Prognosis Analysis
Astragalus Polysaccharides Improve Cisplatin Resistance by Inhibiting EMT of Lung Adenocarcinoma A549/DDP Cells Transplanted into Nude Mice

Related Author

MA Qiong
HUANG Chunxia
HE Jiawei
BAI Yuting
LIU Xingyue
XIONG Yuxuan
ZHONG Yang
LAI Hengzhou

Related Institution

Sichuan Cancer Hospital&Institute,Sichuan Clinical Research Center for Cancer, Sichuan Cancer Prevention and Control Center,Afffliated Cancer Hospital of University of Electronic Science and Technology of China
Sichuan Provincial Key Laboratory of Medicinal Periplaneta americana, Sichuan Good Doctor Panxi Pharmaceutical Co. Ltd.
Cancer Institute,Chengdu University of TCM
Sichuan Provincial Key Laboratory of Traditional Chinese Medicine(TCM) for Prevention and Treatment of Metabolic and Chronic Diseases,Hospital of Chengdu University of TCM
Postdoctoral Mobile Workstation,China Academy of Chinese Medical Sciences